Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-009837
Filing Date
2004-03-30
Accepted
2004-03-29 18:57:21
Documents
8
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2132242z10-k.htm 10-K 529055
3 EXHIBIT 10.38 a2132242zex-10_38.txt EX-10.38 207702
4 EXHIBIT 10.39 a2132242zex-10_39.txt EX-10.39 26165
5 EXHIBIT 21.1 a2132242zex-21_1.txt EX-21.1 178
6 EXHIBIT 23.1 a2132242zex-23_1.htm EX-23.1 2212
7 EXHIBIT 31.1 a2132242zex-31_1.htm EX-31.1 5463
8 EXHIBIT 31.2 a2132242zex-31_2.htm EX-31.2 5450
9 EXHIBIT 32.1 a2132242zex-32_1.txt EX-32.1 1502
  Complete submission text file 0001047469-04-009837.txt   780160
Mailing Address 236 WEST CUMMINGS PARK WOBURN MA 01801
Business Address 236 WEST CUMMINGS PARK WOBURN MA 01801 6179326616
ANIKA THERAPEUTICS INC (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14027 | Film No.: 04697709
SIC: 2836 Biological Products, (No Diagnostic Substances)